Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Genotyping Assay Market Size, Value And Growth Trends Through 2030

The market for genotyping assays has experienced significant expansion lately, projecting a rise from $41.31 billion in 2025 to $50.86 billion in 2026, underpinned by a robust compound annual growth rate (CAGR) of 23.1%. This historic growth trajectory has been propelled by advancements in PCR methodologies, the burgeoning field of molecular diagnostics, the increasing demand for pharmaceutical safety evaluations, the initial commercialization of assays, and persistent interest from academic research communities.

The genotyping assay sector is poised for significant expansion over the coming years, projecting a market value of $116.09 billion by 2030, propelled by a compound annual growth rate of 22.9%. This anticipated surge in the forecast period is underpinned by several key factors, including a heightened focus on biomarker-guided pharmaceutical research, the increasing implementation of automated laboratory systems, the broadening scope of companion diagnostics, a growing need for faster assay methodologies, and the establishment of regulatory approvals. Prominent developments anticipated within this timeframe encompass a greater preference for single nucleotide polymorphism (SNP)-based assays, a wider acceptance of polymerase chain reaction (PCR)-based genotyping techniques, advancements in highly sensitive genotyping assays, the increased utilization of genotyping assays in drug discovery processes, and the incorporation of automation in the handling of assays.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp

Genotyping Assay Market Demand Drivers Creating New Revenue Opportunities

The expanding incidence of genetic conditions is anticipated to be a significant catalyst for the expansion of the genotyping assay market. These genetic disorders, stemming from alterations or defects within a person’s DNA, are becoming more common. Genotyping assays play a crucial role by contrasting the DNA of individuals with these conditions against that of unaffected individuals, thereby identifying specific genetic mutations or variations associated with particular genetic disorders. As a testament to this rising prevalence, in June 2023, Gene People, a UK charity supporting those with genetic conditions, highlighted that one in every 25 children in the UK experiences a genetic disorder, impacting around 30,000 newborns and young children annually, and affecting over 2.4 million individuals in the UK yearly. Consequently, the heightened occurrence of genetic disorders is directly fueling the growth trajectory of the genotyping assay market.

Genotyping Assay Market Segment Analysis Highlighting Growth Areas

The genotyping assay market covered in this report is segmented –

1) By Product And Service: Reagents And Kits, Genotyping Services, Instruments, Bioinformatics

2) By Technology: Microarrays, Polymerase Chain Reaction, Sequencing, Capillary Electrophoresis, Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry, Other Technologies

3) By End-User: Pharmacogenomics, Personalized Medicine And Diagnostics, Animal Genetics, Agricultural Biotechnology, Research And Diagnostic Laboratories, Academic Institutes

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits

2) By Genotyping Services: Genotyping by PCR, Whole Genome Sequencing Services, SNP Genotyping Services

3) By Instruments: PCR Machines, Sequencing Instruments, Microarrays

4) By Bioinformatics: Data Analysis Software, Genotyping Data Management Tools

Genotyping Assay Market Trends Driving Strategic Industry Expansion

Leading entities within the genotyping assay sector are actively contributing to progress in genomic studies, exemplified by the introduction of a CE-IVD marked assay designed for the identification of HIV-1 strains exhibiting resistance to therapies. The Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, which carries the CE-IVD mark, utilizes Sanger sequencing to scrutinize positive human immunodeficiency virus (HIV) samples, thereby pinpointing genetic variations that could confer resistance to standard antiretroviral treatments. As a case in point, Thermo Fisher Scientific, a prominent US corporation, released this CE-IVD marked kit in January 2023. This diagnostic tool offers notable capabilities, including the assessment of genomic mutations in HIV RNA, the detection of drug resistance-associated mutations, and employs the highly regarded Sanger sequencing methodology, all while being optimized for clinical application. The introduction of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has significantly enhanced the diagnostic landscape by improving the identification of HIV-1 strains resistant to treatment, offering convenient pre-prepared reagents and controls, adhering to necessary regulatory standards, demonstrating superior performance metrics, and seamlessly integrating with current sequencing instruments and laboratory protocols.

Genotyping Assay Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the genotyping assay market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs

Access The Complete Genotyping Assay Market Report:

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Genotyping Assay Market Geographic Distribution And Regional Opportunities

North Americawas the largest region in the genotyping assay market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model